Overview
- 115 inspections across 90 sites are on record.
- 230 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-04-16.
At a glance
Inspections
115
Sites
90
Observations
230
Career since
Sep 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| KVK-Tech, Inc. | 16 Apr 2019 | Human Drugs | View 483 → |
| Advanced Accelerator Applications USA, Inc. | 17 May 2018 | Human Drugs | On file |
| Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen) | 9 Feb 2018 | Human Drugs | On file |
| KVK-Tech, Inc. | 27 Jun 2017 | Human Drugs | On file |
| Ferring Production Inc. | 12 Sep 2016 | Human Drugs | On file |
Sites inspected
KVK-Tech, Inc.Newtown, United States2 insp.
Advanced Accelerator Applications USA, Inc.Millburn, United States1 insp.
Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)Ravensburg, Germany1 insp.
Ferring Production Inc.Parsippany, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Valerie C Reed5 shared
Liatte Krueger4 shared
Stephen J Mottola4 shared
Douglas C Kovacs4 shared
Lauren L Vajo3 shared
Michael Serrano3 shared
Daniel J Grabicki3 shared
Nicholas A Violand2 shared
Helen Verdel2 shared
Christina N Maurino2 shared
Full investigator report
Get the verbatim findings behind Michael R Klapal's 230 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site